NCT00006474View on ClinicalTrials.gov

Temozolomide and O6-benzylguanine in Treating Patients With Newly Diagnosed, Recurrent, or Progressive Anaplastic Glioma

PHASE1CompletedINTERVENTIONAL

Timeline

Start Date

March 31, 2001

Primary Completion Date

August 31, 2004

Study Completion Date

August 31, 2004

Conditions

Brain and Central Nervous System Tumors

Interventions

DRUG

O6-benzylguanine

DRUG

temozolomide

PROCEDURE

conventional surgery

Trial Locations (1)

27710

Duke Comprehensive Cancer Center, Durham

Sponsors

Lead Sponsor

Duke University

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Duke University

OTHER